Last reviewed · How we verify

Gestronol Caproate — Competitive Intelligence Brief

Gestronol Caproate (GESTONORONE CAPROATE) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: gestonorone caproate. Area: Other.

phase 2 gestonorone caproate Other Small molecule Live · refreshed every 30 min

Target snapshot

Gestronol Caproate (GESTONORONE CAPROATE). Gestonorone caproate is a prodrug that is converted into gestonorone, a potent androgen receptor agonist.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Gestronol Caproate TARGET GESTONORONE CAPROATE phase 2 gestonorone caproate

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (gestonorone caproate class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Gestronol Caproate — Competitive Intelligence Brief. https://druglandscape.com/ci/gestonorone-caproate. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing